BIO-RAD LABORATORIES, INC. (BIO)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter BIO-RAD LABORATORIES, INC. has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
EPS (diluted)
$13.85
Est. $1.75 · +691.4%
Revenue
$651.0M
Est. $624.0M · +4.3%
Net income
$371.4M
As filed
EPS YoY
+18.7%
vs quarter ended 2025-06-30
Revenue YoY
-0.1%
vs quarter ended 2025-06-30
Next report
Nov 4, 2026
Third-party calendar date, not confirmed by a company filing · est. EPS $2.19
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$8.19
2025-09-30 through 2026-06-30
TTM revenue
$2.59B
2025-09-30 through 2026-06-30
Filed quarters
40
On record here
EPS at or above estimate (4Q)
50%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-08-04 | $13.85 | $651.0M | +18.7% | -0.1% | $1.75 | +691.4% |
| 2026-03-31Q1 FY2026 | 2026-04-30 | $-19.55 | $592.1M | -953.7% | +1.1% | $1.97 | -1092.4% |
| 2025-12-31Q4 FY2025 | 2026-02-13 | $26.59 | $693.2M | +204.0% | +3.9% | $2.57 | +934.6% |
| 2025-09-30Q3 FY2025 | 2025-10-29 | $-12.70 | $653.0M | -154.4% | +0.5% | $2.30 | -652.2% |
| 2025-06-30Q2 FY2025 | 2025-07-31 | $11.67 | $651.6M | +115.3% | +2.1% | $1.93 | +504.7% |
| 2025-03-31Q1 FY2025 | 2025-05-01 | $2.29 | $585.4M | -83.0% | -4.2% | $1.73 | +32.4% |
| 2024-12-31Q4 FY2024 | 2025-02-14 | $-25.57 | $667.5M | -310.6% | -2.0% | $2.86 | -994.1% |
| 2024-09-30Q3 FY2024 | 2024-10-31 | $23.34 | $649.7M | +541.2% | +2.8% | $1.28 | +1723.4% |
| 2024-06-30Q2 FY2024 | 2024-08-02 | $-76.26 | $638.5M | -92.6% | -6.3% | $2.12 | -3697.2% |
| 2024-03-31Q1 FY2024 | 2024-05-08 | $13.45 | $610.8M | +479.7% | -9.8% | $2.15 | +525.6% |
| 2023-12-31Q4 FY2023 | 2024-02-16 | $12.14 | $681.2M | -56.3% | -6.7% | $2.93 | +314.3% |
| 2023-09-30Q3 FY2023 | 2023-10-27 | $3.64 | $632.1M | +166.4% | -7.1% | $2.87 | +26.8% |
| 2023-06-30Q2 FY2023 | 2023-08-04 | $-39.59 | $681.1M | -27.5% | -1.4% | $2.55 | -1652.5% |
| 2023-03-31Q1 FY2023 | 2023-05-05 | $2.32 | $676.8M | +102.1% | -3.3% | $3.24 | -28.4% |
| 2022-12-31Q4 FY2022 | 2023-02-17 | $27.78 | $730.3M | +152.9% | -0.3% | $3.45 | +705.2% |
| 2022-09-30Q3 FY2022 | 2022-10-28 | $-5.48 | $680.8M | -104.2% | -8.9% | $2.59 | -311.6% |
| 2022-06-30Q2 FY2022 | 2022-07-29 | $-31.05 | $691.1M | -202.1% | -3.5% | $2.46 | -1362.2% |
| 2022-03-31Q1 FY2022 | 2022-04-29 | $-112.50 | $700.1M | -446.6% | -3.7% | $2.80 | -4117.9% |
| 2021-12-31Q4 FY2021 | 2022-02-11 | $-52.54 | $732.8M | -288.9% | -7.2% | $2.87 | -1930.7% |
| 2021-09-30Q3 FY2021 | 2021-10-29 | $130.02 | $747.0M | +197.9% | +15.4% | — | — |
| 2021-06-30Q2 FY2021 | 2021-07-30 | $30.41 | $715.9M | -5.4% | +33.4% | — | — |
| 2021-03-31Q1 FY2021 | 2021-04-30 | $32.46 | $726.8M | +42.9% | +27.1% | — | — |
| 2020-12-31Q4 FY2020 | 2021-02-16 | $27.81 | $789.8M | +51.9% | +26.5% | — | — |
| 2020-09-30Q3 FY2020 | 2020-10-30 | $43.64 | $647.3M | +602.8% | +15.5% | — | — |
| 2020-06-30Q2 FY2020 | 2020-07-31 | $32.15 | $536.9M | +61.9% | -6.2% | — | — |
| 2020-03-31Q1 FY2020 | 2020-05-08 | $22.72 | $571.6M | -20.9% | +3.2% | — | — |
| 2019-12-31Q4 FY2019 | 2020-03-02 | $18.31 | $624.5M | +166.0% | +1.2% | — | — |
| 2019-09-30Q3 FY2019 | 2019-11-01 | $-8.68 | $560.6M | -197.6% | +2.8% | — | — |
| 2019-06-30Q2 FY2019 | 2019-08-06 | $19.86 | $572.6M | +123.9% | -0.6% | — | — |
| 2019-03-31Q1 FY2019 | 2019-05-10 | $28.74 | $554.0M | +32.0% | +0.4% | — | — |
| 2018-12-31Q4 FY2018 | 2019-04-01 | $-27.73 | $616.9M | -1108.4% | -0.7% | — | — |
| 2018-09-30Q3 FY2018 | 2018-11-05 | $8.89 | $545.1M | +1117.8% | +2.1% | — | — |
| 2018-06-30Q2 FY2018 | 2018-08-09 | $8.87 | $575.9M | +5117.6% | +14.1% | — | — |
| 2018-03-31Q1 FY2018 | 2018-05-10 | $21.77 | $551.5M | +5209.8% | +10.3% | — | — |
| 2017-12-31Q4 FY2017 | 2018-04-16 | $2.75 | $621.3M | +536.5% | +8.7% | — | — |
| 2017-09-30Q3 FY2017 | 2017-11-09 | $0.73 | $534.1M | +25.9% | +5.0% | — | — |
| 2017-06-30Q2 FY2017 | 2017-08-07 | $0.17 | $504.7M | — | — | — | — |
| 2017-03-31Q1 FY2017 | 2017-05-09 | $0.41 | $500.1M | — | — | — | — |
| 2016-12-31Q4 FY2016 | 2017-03-01 | $-0.63 | $571.5M | — | — | — | — |
| 2016-09-30Q3 FY2016 | 2016-11-02 | $0.58 | $508.7M | — | — | — | — |
Need BIO data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.